ReviewACS omega2021
Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic.
Review in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 57 citations in OpenAlex.
- Capillary-Driven Microfluidic Electrical Screening of Influenza H3N2-Infected A549 Cells Using AgNP-Decorated Laser-Patterned Villous Microstructures.Biosensors · 2026Article
- Deep eutectic solvent-assisted chemosensing of Fe(iii), V(iii), C(ii), and P(ii) ions using a paper-based micro-array decorated by silver nanoparticles.RSC advances · 2025Article
- Article
- A label-free nanowell-based impedance sensor for ten-minute SARS-CoV-2 detection.Sensors & diagnostics · 2025Article
- Net-Shaped DNA Nanostructure-Based Lateral Flow Assays for Rapid and Sensitive SARS-CoV-2 Detection.Analytical chemistry · 2024Article
- Antibody-labelled gold nanoparticles synthesized by laser ablation to detect SARS-CoV-2 antigen spike.ADMET & DMPK · 2024Article
- Advancement in Biosensor Technologies of 2D MaterialIntegrated with Cellulose-Physical Properties.Micromachines · 2023Review
- Advancement in Paper-Based Electrochemical Biosensing and Emerging Diagnostic Methods.Biosensors · 2023Review
- Paper-based electrochemical biosensors for the diagnosis of viral diseases.Mikrochimica acta · 2023Review
- Carbon nanotubes and nanobelts as potential materials for biosensor.Scientific reports · 2023Article
- Review
- A Nitrocellulose Paper-Based Multi-Well Plate for Point-of-Care ELISA.Micromachines · 2022Article
- Nanofiber Based on Electrically Conductive Materials for Biosensor Applications.Biomedical materials & devices (New York, N.Y.) · 2022Review
- SARS-CoV-2-on-Chip for Long COVID Management.Biosensors · 2022Review
- An extracellular matrix biosensing mimetic for evaluating cathepsin as a host target for COVID-19.Analytica chimica acta · 2022Article
- Nanomaterials-based sensors for the detection of COVID-19: A review.Bioengineering & translational medicine · 2022Review
- Photonics enabled intelligence system to identify SARS-CoV 2 mutations.Applied microbiology and biotechnology · 2022Review
- SARS-CoV-2 detection using quantum dot fluorescence immunochromatography combined with isothermal amplification and CRISPR/Cas13a.Biosensors & bioelectronics · 2022Article
- Addressing the global challenges of COVID-19 and other pulmonary diseases with microfluidic technology.Engineering (Beijing, China) · 2022Article
- Sustainable materials and COVID-19 detection biosensor: A brief review.Sensors international · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The appearance and quick spread of the new severe acute respiratory syndrome coronavirus disease, COVID-19, brought major societal challenges. Importantly, suitable medical diagnosis procedures and smooth clinical management of the disease are an emergent need, which must be anchored on novel diagnostic methods and devices. Novel molecular diagnostic tools relying on nucleic acid amplification testing have emerged globally and are the current gold standard in COVID-19 diagnosis. However, the need for widespread testing methodologies for fast, effective testing in multiple epidemiological scenarios remains a crucial step in the fight against the COVID-19 pandemic. Biosensors have previously shown the potential for cost-effective and accessible diagnostics, finding applications in settings where conventional, laboratorial techniques may not be readily employed. Paper- and cellulose-based biosensors can be particularly relevant in pandemic times, for the renewability, possibility of mass production with sustainable methodologies, and safe environmental disposal. In this review, paper-based devices and platforms targeting SARS-CoV-2 are showcased and discussed, as a means to achieve quick and low-cost PoC diagnosis, including detection methodologies for viral genomic material, viral antigen detection, and serological antibody testing. Devices targeting inflammatory markers relevant for COVID-19 are also discussed, as fast, reliable bedside diagnostic tools for patient treatment and follow-up.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.